Does it Matter What Your MS is Called?
What’s in a name? Does it really matter if your MS is called relapsing or progressive, or secondary rather than primary? I’ve never thought so, and it seems as if the International Advisory Committee on Clinical Trials in MS agrees with me. In recommendations published in The Lancet Neurology, the panel calls for new methods to classify MS — methods that reflect the disease’s underlying biology, rather than differences in…Continue Reading